Literature DB >> 203424

Immunosuppressive effects of lymphocyte (type II) and leucocyte (type I) interferon on primary antibody responses in vivo and in vitro.

J L Virelizier, E L Chan, A C Allison.   

Abstract

We have tested the hypothesis that type II interferon (IF), released by immune lymphocytes after in vivo stimulation with tuberculin, has immunosuppressive effects. Mycobacterium bovis (BCG) infected mice injected with tuberculin showed a very intense suppression of antibody response to sheep erythrocytes. Sera containing lymphocyte IF strongly inhibited primary immune responses to sheep erythrocytes in cultures. Addition of macrophages could not counteract the in vitro immunosuppressive effects of lymphocyte IF, suggesting that the main effect is exerted directly on lymphocytes. Sendai virus-induced leucocyte (type I) IF was also shown to have suppressive effects in vivo and in vitro. However, lymphocyte IF was shown to be much more immunosuppressive than a preparation of type I interferon with equivalent antiviral potency. Thus type II IF, as a product of activated lymphocytes, may have a major immunoregulatory role.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 203424      PMCID: PMC1541117     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Inhibition of the primary in vitro antibody response by interferon preparations.

Authors:  H M Johnson; B G Smith; S Baron
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

2.  Inhibition by interferon of delayed-type hypersensitivity in the mouse.

Authors:  E De Maeyer; J De Maeyer-Guignard; M Vandeputte
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

3.  Production by mixed lymphocyte cultures of a type II interferon able to protect macrophages against virus infection.

Authors:  J L Virelizier; A C Allison; E de Maeyer
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

4.  Lymphocyte interferon production and transformation after Herpes simplex infections in humans.

Authors:  L E Rasmussen; G W Jordan; D A Stevens; T C Merigan
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

5.  Prolongation of allograft survival in mice by inducers of interferon.

Authors:  L E Mobraaten; E De Maeyer; J De Maeyer-Guignard
Journal:  Transplantation       Date:  1973-11       Impact factor: 4.939

6.  Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.

Authors:  J S Youngner; S B Salvin
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

Review 7.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

8.  The role of circulating interferon in the modifications of immune responsiveness by mouse hepatitis virus (MHV-3).

Authors:  J L Virelizier; A M Virelizier; A C Allison
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

9.  Regulatory effect of interferon on T cells in vitro.

Authors:  I Heron; K Berg; K Cantell
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.

Authors:  I Gresser; M G Tovey; M E Bandu; C Maury; D Brouty-Boyé
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  6 in total

1.  Human gamma interferon production by cytotoxic T lymphocytes sensitized during hepatitis A virus infection.

Authors:  K Maier; P Gabriel; E Koscielniak; Y D Stierhof; K H Wiedmann; B Flehmig; A Vallbracht
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

2.  Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.

Authors:  M R O'Gorman; J Oger; L F Kastrukoff
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

3.  Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma.

Authors:  J L Pace; S W Russell; R D Schreiber; A Altman; D H Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

4.  Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59.

Authors:  O L Wijburg; M H Heemskerk; C J Boog; N Van Rooijen
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

Review 5.  Virus-related pathology: is the continued presence of the virus necessary?

Authors:  J Huppert; T F Wild
Journal:  Adv Virus Res       Date:  1986       Impact factor: 9.937

6.  Enhanced production of murine interferon gamma by T cells generated in response to bacterial infection.

Authors:  E A Havell; G L Spitalny; P J Patel
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.